Ginseng for the Treatment of Chronic Fatigue Syndrome: A Systematic Review of Clinical Studies

• Published in: Global advances in health and medicine 2022, Vol.11, p.2164957X221079790-2164957X221079790
• Main Authors: Yang, Juan, Shin, Kyung-Min, Abu Dabrh, Abd Moain, Bierle, Dennis M, Zhou, Xuan, Bauer, Brent A., Mohabbat, Arya B
• Format: Article
• Language: English
• Subjects: Chronic fatigue syndrome; Chronic illnesses; Systematic review; Systematic Review and Meta-analyses
• ISSN: 2164-957X; 2164-9561
• DOI: 10.1177/2164957X221079790

Background Chronic fatigue syndrome (CFS) is a complex and often disabling chronic condition emerging worldwide, with no curative or definitive therapy yet identified. Ginseng has been widely used to treat fatigue in other patient groups and conditions; however, a systematic review focusing solely on the impact of ginseng on fatigue in patients with CFS has not been performed. Objective This study aimed to assess the current state of evidence regarding ginseng for CFS. Methods Multiple databases were searched from inception to October 2020. All data was extracted independently and in duplicates. Outcomes of interest included the effectiveness and safety of ginseng in patients with CFS. Results 2 studies enrolling 68 patients were deemed eligible, including one randomized clinical trial and one prospective observational study. The certainty of evidence in the effectiveness outcome was low and moderate from both studies, while the safety evidence was very low as reported from one study. Conclusion Study findings highlight a potential benefit of ginseng therapy in the treatment of CFS. However, we are not able to draw firm conclusions due to limited clinical studies. The paucity of data warrants limited confidence. There is a need for future rigorous studies to provide further evidence.